Skip to main content
CXT
NYSE Manufacturing

Crane NXT Q2 Sales Surge 22% on Antares Vision Boost, but Six-Month Net Income Drops 10%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial Machinery Stocks · Industrial
Sentiment info
Neutral
Importance info
7
Price
$52.37
Mkt Cap
$3.013B
52W Low
$35.705
52W High
$69
52W Position info
47% above low
Off High info
24% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

CXT sits 47% above its 52-week low of $35.705.

Summary

Crane NXT reported Q2 2026 net sales of $493.2M, up 22% year-over-year, but six-month net income fell 10.3% to $41.8M due to acquisition costs and higher interest expense. The company also repriced and increased its Term Loan B to €480M after quarter-end.


Key Events · Earnings and Guidance · CXT

  • Q2 Sales Jump 22%

    Net sales reached $493.2 million in Q2 2026, up from $404.4 million a year ago, driven by the Antares Vision acquisition ($63.7M contribution) and organic growth in the Currency business.

  • Six-Month Net Income Declines

    Net income attributable to common shareholders fell 10.3% to $41.8 million for the first half of 2026, as higher interest expense ($38.8M vs $27.9M) and acquisition-related costs offset revenue gains.

  • Debt Load Increases

    Total debt rose to $1,453.9 million as of June 30, 2026, from $1,139.5 million at year-end 2025, reflecting borrowings to fund the Antares Vision acquisition.

  • Term Loan B Repriced and Upsized

    On July 2, 2026, the company repriced and increased its Term Loan B to €480 million, using proceeds to repay the existing Term Loan B and a portion of Term Loan A, with no change to the December 2032 maturity.


Analysis · CXT · Manufacturing

Crane NXT's second quarter delivered robust top-line growth of 22% to $493.2 million, fueled by the Antares Vision acquisition and organic gains in the Currency business. Yet the six-month view is more nuanced: net income attributable to common shareholders fell 10.3% to $41.8 million, pressured by higher interest expense and acquisition-related costs. The balance sheet mirrors the acquisition financing, with total debt climbing to $1.45 billion. A subsequent repricing and upsizing of the Term Loan B to €480 million signals proactive liability management. In short, the integration is lifting revenue but weighing on near-term profitability.

At the time of this filing, CXT was trading at $52.37 on NYSE in the Manufacturing sector, with a market capitalization of approximately $3B. The 52-week trading range was $35.71 to $69.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CXT - Latest Insights

CXT
Aug 05, 2026, 4:25 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $52.37
Real-time Price: $52.37 info
Change: $0 (0%) info
Market Cap: $3.013B info
CXT
Aug 05, 2026, 4:22 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $52.37
Real-time Price: $52.37 info
Change: $0 (0%) info
Market Cap: $3.013B info
CXT
May 06, 2026, 4:38 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $45.65
Real-time Price: $52.37 info
Change: +$6.72 (+15%) info
Market Cap: $3.013B info
CXT
May 06, 2026, 4:26 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $45.65
Real-time Price: $52.37 info
Change: +$6.72 (+15%) info
Market Cap: $3.013B info
CXT
May 06, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $45.65
Real-time Price: $52.37 info
Change: +$6.72 (+15%) info
Market Cap: $3.013B info